Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphangioleiomyomatosis | 64 | 2024 | 207 | 14.330 |
Why?
|
Tuberous Sclerosis | 79 | 2024 | 1042 | 10.760 |
Why?
|
Tumor Suppressor Proteins | 79 | 2022 | 2810 | 5.460 |
Why?
|
Angiomyolipoma | 33 | 2024 | 189 | 4.370 |
Why?
|
Sirolimus | 29 | 2024 | 1540 | 3.930 |
Why?
|
Birt-Hogg-Dube Syndrome | 10 | 2024 | 40 | 3.650 |
Why?
|
Kidney Neoplasms | 45 | 2024 | 4282 | 3.610 |
Why?
|
TOR Serine-Threonine Kinases | 43 | 2024 | 2062 | 3.520 |
Why?
|
Monomeric GTP-Binding Proteins | 11 | 2022 | 199 | 3.290 |
Why?
|
Carcinoma, Renal Cell | 26 | 2024 | 3187 | 2.880 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 5 | 2024 | 325 | 2.580 |
Why?
|
Pneumothorax | 9 | 2020 | 393 | 1.930 |
Why?
|
Autophagy | 15 | 2021 | 1349 | 1.780 |
Why?
|
Multiprotein Complexes | 14 | 2024 | 1110 | 1.780 |
Why?
|
Neuropeptides | 9 | 2011 | 951 | 1.370 |
Why?
|
Lung Neoplasms | 25 | 2023 | 13586 | 1.290 |
Why?
|
Repressor Proteins | 25 | 2005 | 2982 | 1.250 |
Why?
|
Proto-Oncogene Proteins | 12 | 2021 | 4528 | 1.150 |
Why?
|
Lung Diseases | 9 | 2023 | 1944 | 1.110 |
Why?
|
Protein Kinases | 9 | 2009 | 1611 | 1.090 |
Why?
|
Cysts | 5 | 2021 | 685 | 1.070 |
Why?
|
Genes, Tumor Suppressor | 12 | 2006 | 1062 | 1.020 |
Why?
|
Glutathione | 4 | 2022 | 589 | 1.020 |
Why?
|
Antibiotics, Antineoplastic | 7 | 2021 | 681 | 0.990 |
Why?
|
Lysosomes | 3 | 2021 | 938 | 0.910 |
Why?
|
Vascular Endothelial Growth Factor D | 6 | 2019 | 61 | 0.900 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2023 | 249 | 0.880 |
Why?
|
Amino Acid Transport System y+ | 1 | 2022 | 40 | 0.810 |
Why?
|
Pinocytosis | 2 | 2021 | 63 | 0.800 |
Why?
|
Signal Transduction | 34 | 2024 | 23645 | 0.800 |
Why?
|
Schizosaccharomyces pombe Proteins | 4 | 2013 | 177 | 0.790 |
Why?
|
Cystine | 1 | 2022 | 96 | 0.790 |
Why?
|
gamma-Glutamyltransferase | 2 | 2022 | 144 | 0.790 |
Why?
|
Proteins | 20 | 2012 | 6009 | 0.770 |
Why?
|
Loss of Heterozygosity | 11 | 2016 | 663 | 0.740 |
Why?
|
Estrogens | 5 | 2016 | 1536 | 0.700 |
Why?
|
Neoplastic Stem Cells | 2 | 2022 | 1351 | 0.690 |
Why?
|
Tumor Escape | 1 | 2023 | 372 | 0.680 |
Why?
|
Schizosaccharomyces | 4 | 2013 | 236 | 0.670 |
Why?
|
Cell Transformation, Neoplastic | 11 | 2017 | 2846 | 0.660 |
Why?
|
Kidney Diseases, Cystic | 2 | 2018 | 182 | 0.660 |
Why?
|
Lung | 16 | 2023 | 10099 | 0.660 |
Why?
|
Polycystic Kidney Diseases | 3 | 2016 | 133 | 0.630 |
Why?
|
Class III Phosphatidylinositol 3-Kinases | 1 | 2018 | 17 | 0.630 |
Why?
|
Animals | 80 | 2024 | 169246 | 0.630 |
Why?
|
Polyamines | 1 | 2019 | 133 | 0.630 |
Why?
|
Receptors, Retinoic Acid | 1 | 2019 | 229 | 0.620 |
Why?
|
Hydroxychloroquine | 3 | 2018 | 426 | 0.610 |
Why?
|
Mice | 53 | 2024 | 82029 | 0.610 |
Why?
|
Thoracostomy | 1 | 2018 | 79 | 0.580 |
Why?
|
Chromosomes, Human, Pair 9 | 11 | 1998 | 534 | 0.570 |
Why?
|
MicroRNAs | 4 | 2019 | 3803 | 0.560 |
Why?
|
Humans | 179 | 2024 | 768166 | 0.540 |
Why?
|
Pentose Phosphate Pathway | 2 | 2014 | 126 | 0.540 |
Why?
|
Mice, SCID | 12 | 2021 | 2627 | 0.540 |
Why?
|
Cell Proliferation | 21 | 2024 | 10474 | 0.520 |
Why?
|
Chromosomes, Human, Pair 16 | 6 | 2002 | 341 | 0.510 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2018 | 175 | 0.510 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2017 | 2892 | 0.490 |
Why?
|
Lysophosphatidylcholines | 1 | 2015 | 77 | 0.490 |
Why?
|
Respiratory System Agents | 1 | 2015 | 30 | 0.490 |
Why?
|
Benzophenanthridines | 1 | 2014 | 27 | 0.480 |
Why?
|
Proto-Oncogene Proteins c-raf | 2 | 2006 | 205 | 0.470 |
Why?
|
Receptors, LDL | 1 | 2017 | 493 | 0.470 |
Why?
|
Cell Line | 17 | 2021 | 15597 | 0.470 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3948 | 0.460 |
Why?
|
6-Aminonicotinamide | 1 | 2013 | 8 | 0.460 |
Why?
|
Fibroblasts | 4 | 2021 | 4176 | 0.450 |
Why?
|
Embryo, Mammalian | 2 | 2019 | 1676 | 0.450 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 3 | 2008 | 166 | 0.450 |
Why?
|
Ribosomal Protein S6 | 4 | 2007 | 70 | 0.450 |
Why?
|
TRPP Cation Channels | 4 | 2021 | 177 | 0.440 |
Why?
|
Mutation | 35 | 2021 | 30238 | 0.430 |
Why?
|
Estradiol | 6 | 2014 | 1951 | 0.430 |
Why?
|
Sequence Analysis, RNA | 3 | 2021 | 2040 | 0.430 |
Why?
|
Enzyme Inhibitors | 5 | 2020 | 3728 | 0.420 |
Why?
|
Plakophilins | 1 | 2012 | 32 | 0.420 |
Why?
|
Immunotherapy | 2 | 2019 | 4755 | 0.410 |
Why?
|
Oligopeptides | 1 | 2018 | 1194 | 0.410 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2017 | 702 | 0.410 |
Why?
|
Adherens Junctions | 1 | 2012 | 90 | 0.400 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1890 | 0.400 |
Why?
|
Neoplasm Proteins | 5 | 2020 | 3603 | 0.390 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 719 | 0.390 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2014 | 2059 | 0.380 |
Why?
|
Membrane Glycoproteins | 2 | 2024 | 3711 | 0.370 |
Why?
|
Mice, Knockout | 13 | 2024 | 14488 | 0.370 |
Why?
|
Cell Cycle Proteins | 5 | 2014 | 3445 | 0.360 |
Why?
|
HeLa Cells | 4 | 2021 | 3074 | 0.360 |
Why?
|
Arginine | 2 | 2005 | 932 | 0.360 |
Why?
|
Phosphorylation | 14 | 2021 | 8317 | 0.360 |
Why?
|
Lipid Metabolism | 2 | 2018 | 1904 | 0.360 |
Why?
|
Cell Line, Tumor | 19 | 2024 | 17140 | 0.360 |
Why?
|
Immunoblotting | 7 | 2018 | 1647 | 0.350 |
Why?
|
Chromosomes, Human, Pair 13 | 2 | 2003 | 192 | 0.350 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 11928 | 0.340 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 5 | 2013 | 103 | 0.340 |
Why?
|
Sense Organs | 1 | 2009 | 21 | 0.340 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2023 | 2885 | 0.340 |
Why?
|
Immunosuppressive Agents | 4 | 2018 | 4206 | 0.330 |
Why?
|
Neoplasms, Multiple Primary | 4 | 2019 | 594 | 0.330 |
Why?
|
Kidney | 14 | 2021 | 7064 | 0.330 |
Why?
|
Ligases | 2 | 2002 | 333 | 0.320 |
Why?
|
Tumor Cells, Cultured | 7 | 2019 | 6124 | 0.320 |
Why?
|
Homeostasis | 3 | 2017 | 3348 | 0.320 |
Why?
|
Up-Regulation | 5 | 2021 | 4146 | 0.320 |
Why?
|
Gene Expression Profiling | 8 | 2019 | 9538 | 0.310 |
Why?
|
Lymphangiogenesis | 1 | 2010 | 171 | 0.310 |
Why?
|
DNA Mutational Analysis | 8 | 2014 | 4120 | 0.300 |
Why?
|
Mice, Inbred NOD | 4 | 2021 | 1837 | 0.300 |
Why?
|
Chromosome Deletion | 4 | 2014 | 1385 | 0.300 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2014 | 2909 | 0.300 |
Why?
|
HEK293 Cells | 4 | 2021 | 4283 | 0.300 |
Why?
|
Cholesterol | 1 | 2017 | 2914 | 0.300 |
Why?
|
Cell Movement | 7 | 2019 | 5210 | 0.290 |
Why?
|
Drosophila Proteins | 2 | 2009 | 1712 | 0.290 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10266 | 0.290 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 797 | 0.280 |
Why?
|
Cilia | 2 | 2008 | 498 | 0.280 |
Why?
|
Apoptosis | 8 | 2023 | 9523 | 0.280 |
Why?
|
Mice, Nude | 7 | 2022 | 3623 | 0.280 |
Why?
|
rho GTP-Binding Proteins | 2 | 2012 | 279 | 0.280 |
Why?
|
Drug Discovery | 1 | 2015 | 1068 | 0.280 |
Why?
|
Cell Survival | 5 | 2014 | 5777 | 0.280 |
Why?
|
Carrier Proteins | 4 | 2017 | 4937 | 0.270 |
Why?
|
Mitochondria | 2 | 2017 | 3681 | 0.260 |
Why?
|
Female | 68 | 2024 | 397192 | 0.260 |
Why?
|
Neoplasms | 8 | 2022 | 22371 | 0.260 |
Why?
|
Gene Expression Regulation, Fungal | 2 | 2013 | 497 | 0.260 |
Why?
|
Carcinoma | 2 | 2009 | 2332 | 0.250 |
Why?
|
Receptor, Notch1 | 2 | 2019 | 519 | 0.250 |
Why?
|
Glucose | 3 | 2014 | 4352 | 0.240 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2014 | 1169 | 0.240 |
Why?
|
G1 Phase | 2 | 2005 | 403 | 0.240 |
Why?
|
Tissue Banks | 1 | 2006 | 183 | 0.240 |
Why?
|
Receptors, Notch | 1 | 2009 | 751 | 0.240 |
Why?
|
Interphase | 2 | 2003 | 227 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 7 | 2020 | 18065 | 0.240 |
Why?
|
Disease Models, Animal | 14 | 2021 | 18349 | 0.230 |
Why?
|
Oxidative Stress | 4 | 2023 | 3139 | 0.230 |
Why?
|
Centrosome | 1 | 2005 | 210 | 0.230 |
Why?
|
Cell Differentiation | 5 | 2017 | 11669 | 0.230 |
Why?
|
von Hippel-Lindau Disease | 3 | 2004 | 154 | 0.230 |
Why?
|
Transcription Factors | 7 | 2023 | 12168 | 0.230 |
Why?
|
RNA, Small Interfering | 5 | 2022 | 3428 | 0.230 |
Why?
|
Receptors, Progesterone | 2 | 2000 | 1160 | 0.230 |
Why?
|
Leucine | 1 | 2005 | 547 | 0.220 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 410 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2023 | 2457 | 0.220 |
Why?
|
Anoikis | 2 | 2016 | 49 | 0.220 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 4 | 2017 | 304 | 0.210 |
Why?
|
Cell Adhesion | 3 | 2015 | 3096 | 0.210 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2004 | 1901 | 0.210 |
Why?
|
Vital Capacity | 2 | 2017 | 996 | 0.210 |
Why?
|
Cyclins | 1 | 2005 | 606 | 0.210 |
Why?
|
Molecular Targeted Therapy | 4 | 2022 | 2830 | 0.210 |
Why?
|
Glutathione Disulfide | 1 | 2022 | 32 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2013 | 478 | 0.210 |
Why?
|
MAP Kinase Signaling System | 3 | 2013 | 1494 | 0.210 |
Why?
|
Cysteine Proteases | 1 | 2022 | 13 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2020 | 8647 | 0.200 |
Why?
|
Canavanine | 3 | 2007 | 14 | 0.200 |
Why?
|
Serine | 2 | 2021 | 831 | 0.190 |
Why?
|
Genes, Regulator | 1 | 2023 | 373 | 0.190 |
Why?
|
Clinical Trials as Topic | 3 | 2015 | 8054 | 0.190 |
Why?
|
Biological Transport | 2 | 2022 | 2085 | 0.190 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2021 | 128 | 0.190 |
Why?
|
Ritanserin | 1 | 2021 | 10 | 0.190 |
Why?
|
Tamoxifen | 2 | 2003 | 966 | 0.190 |
Why?
|
Down-Regulation | 4 | 2021 | 2937 | 0.190 |
Why?
|
Carbonic Anhydrase II | 1 | 2021 | 21 | 0.190 |
Why?
|
Fungal Proteins | 1 | 2005 | 906 | 0.190 |
Why?
|
Diacylglycerol Kinase | 1 | 2021 | 47 | 0.180 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2019 | 757 | 0.180 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2019 | 3611 | 0.180 |
Why?
|
Interleukin-6 | 2 | 2021 | 3228 | 0.180 |
Why?
|
Phosphoserine | 1 | 2021 | 204 | 0.180 |
Why?
|
Biological Assay | 2 | 2016 | 628 | 0.180 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2020 | 30 | 0.180 |
Why?
|
RNA, Messenger | 5 | 2022 | 12800 | 0.180 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2020 | 39 | 0.180 |
Why?
|
Chromosome Mapping | 12 | 2003 | 4620 | 0.180 |
Why?
|
Transaminases | 1 | 2021 | 199 | 0.180 |
Why?
|
Pulmonary Surfactants | 1 | 2021 | 169 | 0.180 |
Why?
|
Mice, Inbred C57BL | 7 | 2022 | 22379 | 0.180 |
Why?
|
Immunohistochemistry | 11 | 2019 | 11095 | 0.180 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2002 | 218 | 0.170 |
Why?
|
IMP Dehydrogenase | 1 | 2020 | 34 | 0.170 |
Why?
|
Rats | 10 | 2021 | 23760 | 0.170 |
Why?
|
Ribosomal Protein S6 Kinases | 3 | 2006 | 203 | 0.170 |
Why?
|
Neoplasm Metastasis | 6 | 2012 | 4912 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 5 | 2019 | 5703 | 0.170 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2021 | 135 | 0.170 |
Why?
|
Ribonucleosides | 1 | 2020 | 79 | 0.170 |
Why?
|
Wnt2 Protein | 1 | 2019 | 28 | 0.170 |
Why?
|
COUP Transcription Factor II | 1 | 2019 | 19 | 0.170 |
Why?
|
Nodal Protein | 1 | 2019 | 36 | 0.170 |
Why?
|
Research Design | 2 | 2015 | 6211 | 0.160 |
Why?
|
Molecular Sequence Data | 12 | 2014 | 17622 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 3 | 2013 | 1074 | 0.160 |
Why?
|
Immunoenzyme Techniques | 5 | 2006 | 1703 | 0.160 |
Why?
|
Base Sequence | 12 | 2019 | 12421 | 0.160 |
Why?
|
Organoids | 2 | 2022 | 743 | 0.160 |
Why?
|
Amiloride | 1 | 2018 | 116 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2013 | 1151 | 0.160 |
Why?
|
Endostatins | 1 | 2019 | 167 | 0.160 |
Why?
|
Neurobiology | 1 | 1999 | 135 | 0.150 |
Why?
|
Cell Nucleus | 3 | 2021 | 2885 | 0.150 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2018 | 72 | 0.150 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2020 | 257 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2019 | 2954 | 0.150 |
Why?
|
Cytoplasm | 2 | 2003 | 1505 | 0.150 |
Why?
|
Cells, Cultured | 6 | 2019 | 19015 | 0.150 |
Why?
|
Transfection | 6 | 2014 | 5755 | 0.150 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2020 | 319 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2018 | 118 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2001 | 467 | 0.150 |
Why?
|
Mycophenolic Acid | 1 | 2020 | 348 | 0.150 |
Why?
|
Microsatellite Repeats | 4 | 2006 | 785 | 0.150 |
Why?
|
Reactive Oxygen Species | 3 | 2014 | 2149 | 0.150 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 130 | 0.140 |
Why?
|
Lung Diseases, Fungal | 1 | 2018 | 124 | 0.140 |
Why?
|
Genetic Linkage | 4 | 2006 | 2342 | 0.140 |
Why?
|
Alleles | 5 | 2007 | 6894 | 0.140 |
Why?
|
Calcium-Binding Proteins | 2 | 2017 | 1083 | 0.140 |
Why?
|
Chloroquine | 2 | 2021 | 276 | 0.140 |
Why?
|
Genes, p53 | 2 | 2011 | 714 | 0.140 |
Why?
|
Pulmonary Alveoli | 1 | 2020 | 665 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2023 | 1625 | 0.140 |
Why?
|
Amino Acid Sequence | 8 | 2013 | 13421 | 0.140 |
Why?
|
Interferons | 1 | 2021 | 720 | 0.140 |
Why?
|
Phosphoproteins | 3 | 2014 | 2451 | 0.140 |
Why?
|
Adenocarcinoma | 3 | 2006 | 6395 | 0.140 |
Why?
|
Polymorphism, Genetic | 5 | 2007 | 4249 | 0.130 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2019 | 381 | 0.130 |
Why?
|
Dextrans | 1 | 2018 | 574 | 0.130 |
Why?
|
Naphthyridines | 2 | 2015 | 185 | 0.130 |
Why?
|
Exons | 6 | 2002 | 2394 | 0.130 |
Why?
|
Endothelium, Lymphatic | 1 | 2016 | 63 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3626 | 0.130 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2019 | 2195 | 0.130 |
Why?
|
RNA Interference | 4 | 2017 | 2832 | 0.130 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2019 | 335 | 0.130 |
Why?
|
Mosaicism | 1 | 2019 | 480 | 0.130 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13676 | 0.130 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 663 | 0.130 |
Why?
|
Polymorphism, Single-Stranded Conformational | 4 | 2006 | 325 | 0.130 |
Why?
|
Genetic Markers | 8 | 2014 | 2603 | 0.130 |
Why?
|
Mucositis | 1 | 2017 | 108 | 0.130 |
Why?
|
Phenotype | 9 | 2024 | 16726 | 0.130 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2015 | 25 | 0.130 |
Why?
|
Germ-Line Mutation | 5 | 2020 | 1885 | 0.130 |
Why?
|
Shock | 1 | 2018 | 316 | 0.130 |
Why?
|
Mutation, Missense | 2 | 2004 | 2592 | 0.130 |
Why?
|
Male | 33 | 2024 | 364719 | 0.120 |
Why?
|
Protein Transport | 1 | 2021 | 1951 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2019 | 725 | 0.120 |
Why?
|
Models, Biological | 7 | 2015 | 9495 | 0.120 |
Why?
|
Lymphocytes | 1 | 2023 | 2614 | 0.120 |
Why?
|
Phospholipases A2 | 1 | 2015 | 197 | 0.120 |
Why?
|
Biopsy | 5 | 2016 | 6793 | 0.120 |
Why?
|
Nucleotides | 1 | 2017 | 455 | 0.120 |
Why?
|
Renal Insufficiency | 1 | 2021 | 812 | 0.120 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2003 | 1536 | 0.120 |
Why?
|
Pneumonia, Bacterial | 1 | 2018 | 320 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 891 | 0.120 |
Why?
|
Biomedical Research | 3 | 2016 | 3463 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 6 | 2024 | 20760 | 0.120 |
Why?
|
Aging | 1 | 2014 | 8744 | 0.120 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2007 | 2748 | 0.120 |
Why?
|
Respiratory Function Tests | 3 | 2020 | 1695 | 0.120 |
Why?
|
Protein Binding | 4 | 2012 | 9343 | 0.120 |
Why?
|
Receptors, Estrogen | 2 | 2000 | 2253 | 0.120 |
Why?
|
Amino Acids | 2 | 2013 | 1716 | 0.120 |
Why?
|
Age of Onset | 1 | 2021 | 3347 | 0.110 |
Why?
|
Cell Death | 2 | 2022 | 1679 | 0.110 |
Why?
|
Epithelium | 2 | 2015 | 1607 | 0.110 |
Why?
|
Cell Shape | 1 | 2015 | 371 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2021 | 9561 | 0.110 |
Why?
|
Oncogenes | 2 | 2023 | 1234 | 0.110 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.110 |
Why?
|
Mice, Inbred BALB C | 2 | 2022 | 6231 | 0.110 |
Why?
|
Cell Division | 4 | 2006 | 4473 | 0.110 |
Why?
|
Cough | 1 | 2018 | 598 | 0.110 |
Why?
|
Mice, Inbred A | 1 | 2013 | 245 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3814 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 474 | 0.110 |
Why?
|
Opportunistic Infections | 1 | 2017 | 375 | 0.110 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2013 | 53 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1240 | 0.110 |
Why?
|
DNA, Neoplasm | 3 | 2006 | 1744 | 0.110 |
Why?
|
Dimerization | 2 | 2006 | 887 | 0.110 |
Why?
|
Membrane Proteins | 3 | 2011 | 7876 | 0.110 |
Why?
|
Dogs | 2 | 2012 | 3845 | 0.110 |
Why?
|
Kidney Diseases | 1 | 2004 | 2100 | 0.110 |
Why?
|
Adult | 27 | 2024 | 223646 | 0.110 |
Why?
|
Teratogens | 1 | 2013 | 119 | 0.110 |
Why?
|
Lung Transplantation | 1 | 2002 | 1309 | 0.110 |
Why?
|
gamma Catenin | 1 | 2012 | 45 | 0.100 |
Why?
|
Keratin-14 | 1 | 2012 | 57 | 0.100 |
Why?
|
Desmosomes | 1 | 2012 | 73 | 0.100 |
Why?
|
Catenins | 1 | 2012 | 44 | 0.100 |
Why?
|
Caspase 1 | 1 | 2013 | 227 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2004 | 0.100 |
Why?
|
Blotting, Western | 5 | 2016 | 5027 | 0.100 |
Why?
|
Prostaglandins | 1 | 2014 | 398 | 0.100 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2474 | 0.100 |
Why?
|
Maximum Tolerated Dose | 1 | 2015 | 899 | 0.100 |
Why?
|
Heme Oxygenase-1 | 1 | 2014 | 364 | 0.100 |
Why?
|
Protein Biosynthesis | 1 | 1999 | 2094 | 0.100 |
Why?
|
Cardiomegaly | 1 | 2014 | 591 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2009 | 1245 | 0.100 |
Why?
|
Forced Expiratory Volume | 1 | 2017 | 1831 | 0.100 |
Why?
|
Pericytes | 1 | 2014 | 299 | 0.090 |
Why?
|
Immunoprecipitation | 2 | 2021 | 874 | 0.090 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1321 | 0.090 |
Why?
|
Bronchi | 1 | 2015 | 850 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6316 | 0.090 |
Why?
|
GTP Phosphohydrolases | 2 | 2005 | 525 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 4580 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2023 | 3080 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1408 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15454 | 0.090 |
Why?
|
Mass Spectrometry | 2 | 2015 | 2202 | 0.090 |
Why?
|
Chest Pain | 1 | 2018 | 1101 | 0.090 |
Why?
|
Precipitin Tests | 2 | 2004 | 816 | 0.090 |
Why?
|
Exosomes | 1 | 2015 | 422 | 0.090 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7608 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 1995 | 717 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2022 | 2232 | 0.090 |
Why?
|
Pluripotent Stem Cells | 1 | 2017 | 809 | 0.090 |
Why?
|
Nephrology | 1 | 2014 | 270 | 0.090 |
Why?
|
Heterozygote | 5 | 2017 | 2798 | 0.090 |
Why?
|
Sirtuins | 1 | 2013 | 322 | 0.090 |
Why?
|
Forecasting | 1 | 2019 | 2945 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2007 | 5863 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 2 | 2009 | 1966 | 0.090 |
Why?
|
Integrases | 1 | 2012 | 520 | 0.090 |
Why?
|
Glutamine | 1 | 2013 | 577 | 0.090 |
Why?
|
Risk Assessment | 6 | 2021 | 24315 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1320 | 0.090 |
Why?
|
Dyspnea | 1 | 2018 | 1352 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1854 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2726 | 0.080 |
Why?
|
Genes, Dominant | 2 | 2004 | 855 | 0.080 |
Why?
|
Epidermis | 1 | 2012 | 539 | 0.080 |
Why?
|
Amino Acid Transport Systems | 2 | 2013 | 34 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2015 | 2923 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2022 | 3589 | 0.080 |
Why?
|
Glioblastoma | 2 | 2009 | 3464 | 0.080 |
Why?
|
Flow Cytometry | 4 | 2021 | 5902 | 0.080 |
Why?
|
Genetic Testing | 3 | 2021 | 3591 | 0.080 |
Why?
|
Respiratory Tract Infections | 1 | 2017 | 1014 | 0.080 |
Why?
|
Genotype | 5 | 2019 | 13045 | 0.080 |
Why?
|
Hair | 1 | 2012 | 508 | 0.080 |
Why?
|
Brain Neoplasms | 3 | 2002 | 9118 | 0.080 |
Why?
|
Melanoma | 1 | 2007 | 5706 | 0.080 |
Why?
|
Women's Health | 1 | 2018 | 2082 | 0.080 |
Why?
|
Headache | 1 | 2017 | 1263 | 0.080 |
Why?
|
DNA | 5 | 2006 | 7214 | 0.080 |
Why?
|
Prognosis | 5 | 2018 | 30010 | 0.080 |
Why?
|
Muscle, Smooth | 2 | 2004 | 931 | 0.080 |
Why?
|
Protein Structure, Tertiary | 2 | 2006 | 3772 | 0.070 |
Why?
|
Plasmids | 2 | 2004 | 2269 | 0.070 |
Why?
|
Polymerase Chain Reaction | 8 | 2014 | 6082 | 0.070 |
Why?
|
Ethionine | 1 | 2007 | 10 | 0.070 |
Why?
|
Middle Aged | 17 | 2024 | 223492 | 0.070 |
Why?
|
Brain | 6 | 2016 | 27360 | 0.070 |
Why?
|
Genome, Human | 2 | 2018 | 4446 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3671 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 979 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4860 | 0.070 |
Why?
|
Oxygen Consumption | 1 | 2013 | 1880 | 0.070 |
Why?
|
Young Adult | 6 | 2024 | 60066 | 0.070 |
Why?
|
Ovariectomy | 1 | 2009 | 613 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 434 | 0.070 |
Why?
|
Gene Deletion | 2 | 2005 | 2675 | 0.070 |
Why?
|
Risk Factors | 5 | 2018 | 74944 | 0.070 |
Why?
|
Antibody Specificity | 2 | 1999 | 1065 | 0.070 |
Why?
|
Microscopy, Fluorescence | 3 | 2012 | 2633 | 0.070 |
Why?
|
Indoles | 1 | 2014 | 1836 | 0.060 |
Why?
|
Gene Knockdown Techniques | 3 | 2017 | 1606 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2014 | 9419 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2017 | 65371 | 0.060 |
Why?
|
Nevus | 1 | 2007 | 205 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 1681 | 0.060 |
Why?
|
Pedigree | 4 | 2019 | 4539 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2011 | 1750 | 0.060 |
Why?
|
Testis | 1 | 2009 | 783 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2013 | 1738 | 0.060 |
Why?
|
Cell Fractionation | 1 | 2005 | 247 | 0.060 |
Why?
|
Haploinsufficiency | 2 | 2017 | 334 | 0.060 |
Why?
|
NF-kappa B | 1 | 2013 | 2493 | 0.060 |
Why?
|
Genes, Lethal | 1 | 2005 | 224 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3800 | 0.060 |
Why?
|
Blotting, Northern | 2 | 2004 | 1550 | 0.060 |
Why?
|
Paraffin Embedding | 1 | 2006 | 307 | 0.060 |
Why?
|
Guanosine Diphosphate | 1 | 2004 | 79 | 0.060 |
Why?
|
Angiofibroma | 2 | 2002 | 55 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1982 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1798 | 0.060 |
Why?
|
RNA | 2 | 2004 | 2720 | 0.060 |
Why?
|
Ovary | 1 | 2009 | 965 | 0.060 |
Why?
|
Rare Diseases | 1 | 2010 | 631 | 0.060 |
Why?
|
Protein Prenylation | 1 | 2004 | 70 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2056 | 0.060 |
Why?
|
DNA, Complementary | 3 | 1997 | 1989 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2014 | 21206 | 0.060 |
Why?
|
Biological Evolution | 1 | 2009 | 1076 | 0.060 |
Why?
|
Peer Review, Research | 1 | 2007 | 344 | 0.060 |
Why?
|
Hyperplasia | 2 | 2014 | 1151 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2011 | 1250 | 0.050 |
Why?
|
Cyclin B | 1 | 2003 | 104 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 13014 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2020 | 2014 | 0.050 |
Why?
|
G2 Phase | 1 | 2003 | 134 | 0.050 |
Why?
|
Philadelphia Chromosome | 2 | 1994 | 119 | 0.050 |
Why?
|
Benzamides | 1 | 2009 | 1379 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10760 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 1996 | 0.050 |
Why?
|
Receptors, Steroid | 1 | 2003 | 156 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 16045 | 0.050 |
Why?
|
Consensus | 2 | 2024 | 3212 | 0.050 |
Why?
|
CDC2 Protein Kinase | 1 | 2003 | 212 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 3 | 1995 | 781 | 0.050 |
Why?
|
Glioma | 1 | 1997 | 3503 | 0.050 |
Why?
|
Glucosephosphate Dehydrogenase | 2 | 2014 | 209 | 0.050 |
Why?
|
Receptors, Angiotensin | 1 | 2022 | 141 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4503 | 0.050 |
Why?
|
Glycogen | 1 | 2003 | 252 | 0.050 |
Why?
|
Drosophila | 1 | 2009 | 1513 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2004 | 564 | 0.050 |
Why?
|
Glutamic Acid | 2 | 2014 | 1191 | 0.050 |
Why?
|
Mitosis | 1 | 2007 | 1178 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2004 | 340 | 0.050 |
Why?
|
Rats, Nude | 1 | 2021 | 105 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2002 | 164 | 0.050 |
Why?
|
Engineering | 1 | 2021 | 56 | 0.050 |
Why?
|
Angiolipoma | 1 | 2021 | 12 | 0.050 |
Why?
|
Wound Healing | 1 | 2012 | 2809 | 0.050 |
Why?
|
Phosphatidic Acids | 1 | 2021 | 50 | 0.050 |
Why?
|
Lung Compliance | 1 | 2021 | 207 | 0.050 |
Why?
|
Adenosine Triphosphatases | 1 | 2005 | 842 | 0.050 |
Why?
|
Cytochromes c | 1 | 2021 | 173 | 0.050 |
Why?
|
Sequence Homology | 1 | 2001 | 197 | 0.050 |
Why?
|
Lymphangiomyoma | 1 | 2000 | 9 | 0.050 |
Why?
|
ras Proteins | 1 | 2006 | 1058 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20227 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 2360 | 0.050 |
Why?
|
Proton-Translocating ATPases | 1 | 2021 | 112 | 0.040 |
Why?
|
Aged | 7 | 2019 | 171504 | 0.040 |
Why?
|
Epilepsy | 1 | 2016 | 3327 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 1 | 2021 | 611 | 0.040 |
Why?
|
Cell Cycle | 2 | 2013 | 2932 | 0.040 |
Why?
|
Giant Cells | 1 | 2001 | 187 | 0.040 |
Why?
|
Microscopy, Confocal | 2 | 2014 | 1972 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1683 | 0.040 |
Why?
|
Asthma | 2 | 2018 | 6291 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2020 | 190 | 0.040 |
Why?
|
Genomics | 1 | 2016 | 5926 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2007 | 1767 | 0.040 |
Why?
|
Binding Sites | 2 | 2009 | 6020 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2000 | 151 | 0.040 |
Why?
|
Adolescent | 7 | 2024 | 89169 | 0.040 |
Why?
|
Survival Analysis | 3 | 2018 | 10101 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2298 | 0.040 |
Why?
|
Molecular Weight | 2 | 1998 | 2173 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3620 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 610 | 0.040 |
Why?
|
Phenylenediamines | 1 | 2019 | 89 | 0.040 |
Why?
|
Endocrine Glands | 1 | 1999 | 101 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2002 | 3474 | 0.040 |
Why?
|
Gene Expression | 2 | 2021 | 7598 | 0.040 |
Why?
|
Receptors, GABA | 1 | 2001 | 312 | 0.040 |
Why?
|
Hybrid Cells | 3 | 1994 | 421 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2015 | 3703 | 0.040 |
Why?
|
Microfilament Proteins | 2 | 1994 | 1133 | 0.040 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1994 | 686 | 0.040 |
Why?
|
Child | 8 | 2014 | 80917 | 0.040 |
Why?
|
Rats, Mutant Strains | 1 | 1997 | 60 | 0.040 |
Why?
|
Liposomes | 1 | 2022 | 790 | 0.040 |
Why?
|
Cosmids | 2 | 1995 | 105 | 0.040 |
Why?
|
Allosteric Regulation | 1 | 2019 | 426 | 0.040 |
Why?
|
Restriction Mapping | 2 | 1995 | 849 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1998 | 323 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 806 | 0.040 |
Why?
|
Astrocytoma | 1 | 2002 | 774 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39348 | 0.030 |
Why?
|
Kidney Tubules | 1 | 1999 | 454 | 0.030 |
Why?
|
Phospholipids | 1 | 2021 | 787 | 0.030 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2018 | 325 | 0.030 |
Why?
|
Epigenomics | 1 | 2023 | 960 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1135 | 0.030 |
Why?
|
Pleurodesis | 1 | 2017 | 49 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 2022 | 1207 | 0.030 |
Why?
|
Drug Synergism | 1 | 2021 | 1760 | 0.030 |
Why?
|
Melanoma-Specific Antigens | 1 | 1996 | 73 | 0.030 |
Why?
|
RNA, Ribosomal | 1 | 2017 | 227 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2017 | 404 | 0.030 |
Why?
|
Adenoma, Oxyphilic | 1 | 1998 | 152 | 0.030 |
Why?
|
Rhabdomyoma | 1 | 1996 | 56 | 0.030 |
Why?
|
Treatment Failure | 1 | 2002 | 2661 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2022 | 936 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2014 | 2521 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2000 | 1497 | 0.030 |
Why?
|
Education | 1 | 2018 | 533 | 0.030 |
Why?
|
Behavior | 1 | 2018 | 542 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2065 | 0.030 |
Why?
|
Neural Crest | 1 | 2017 | 278 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2000 | 1743 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2014 | 3590 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1999 | 2300 | 0.030 |
Why?
|
Point Mutation | 1 | 2000 | 1596 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 1995 | 91 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5797 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 710 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2018 | 465 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2014 | 93 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5341 | 0.030 |
Why?
|
Hominidae | 1 | 1994 | 68 | 0.030 |
Why?
|
Glucose Transporter Type 2 | 1 | 2014 | 61 | 0.030 |
Why?
|
Metabolomics | 2 | 2014 | 1674 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2017 | 605 | 0.030 |
Why?
|
Poland | 1 | 2014 | 197 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36743 | 0.030 |
Why?
|
Receptors, Estradiol | 1 | 2013 | 18 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2014 | 186 | 0.030 |
Why?
|
Carcinoma, Papillary | 1 | 1999 | 793 | 0.030 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2013 | 42 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1008 | 0.030 |
Why?
|
Drug Implants | 1 | 2014 | 230 | 0.030 |
Why?
|
Registries | 1 | 2010 | 8375 | 0.030 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 1994 | 313 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2120 | 0.030 |
Why?
|
Activating Transcription Factors | 1 | 2013 | 30 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 801 | 0.030 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2013 | 83 | 0.030 |
Why?
|
Glutamate Dehydrogenase | 1 | 2013 | 50 | 0.030 |
Why?
|
Mesoderm | 1 | 2016 | 679 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2013 | 2393 | 0.030 |
Why?
|
NADP | 1 | 2014 | 229 | 0.030 |
Why?
|
GTP-Binding Proteins | 1 | 1997 | 948 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 638 | 0.030 |
Why?
|
Collagen Type IV | 1 | 2013 | 125 | 0.030 |
Why?
|
Time Factors | 3 | 2017 | 40218 | 0.030 |
Why?
|
Nail-Patella Syndrome | 1 | 1992 | 12 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9615 | 0.030 |
Why?
|
Valine | 1 | 2014 | 410 | 0.030 |
Why?
|
Breath Tests | 1 | 2014 | 300 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1505 | 0.030 |
Why?
|
Centromere | 1 | 1993 | 214 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2014 | 438 | 0.030 |
Why?
|
Porphyrins | 1 | 2014 | 352 | 0.030 |
Why?
|
Age Distribution | 1 | 1998 | 2873 | 0.030 |
Why?
|
Contractile Proteins | 1 | 1993 | 240 | 0.030 |
Why?
|
Color Perception | 1 | 1993 | 212 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2018 | 964 | 0.020 |
Why?
|
Rabbits | 1 | 1998 | 4772 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2001 | 4786 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1120 | 0.020 |
Why?
|
Airway Remodeling | 1 | 2013 | 133 | 0.020 |
Why?
|
Computer Simulation | 2 | 2016 | 6283 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1993 | 348 | 0.020 |
Why?
|
Dystonia Musculorum Deformans | 1 | 1992 | 158 | 0.020 |
Why?
|
Arabidopsis Proteins | 1 | 2013 | 261 | 0.020 |
Why?
|
Chromatin | 2 | 2016 | 2981 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5804 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2017 | 863 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2014 | 598 | 0.020 |
Why?
|
Health Priorities | 1 | 2014 | 380 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2013 | 461 | 0.020 |
Why?
|
Lipoxins | 1 | 2014 | 419 | 0.020 |
Why?
|
ABO Blood-Group System | 1 | 1993 | 381 | 0.020 |
Why?
|
Translocation, Genetic | 2 | 1995 | 1394 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1992 | 1305 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2013 | 749 | 0.020 |
Why?
|
Goals | 1 | 2016 | 717 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 1993 | 640 | 0.020 |
Why?
|
Sequence Alignment | 1 | 1995 | 2179 | 0.020 |
Why?
|
Infant | 2 | 2006 | 36535 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 984 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22291 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1676 | 0.020 |
Why?
|
Nanoparticles | 1 | 2022 | 1985 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1758 | 0.020 |
Why?
|
Farnesol | 1 | 2009 | 20 | 0.020 |
Why?
|
Organ Specificity | 1 | 1995 | 1968 | 0.020 |
Why?
|
Dystonia | 1 | 1993 | 378 | 0.020 |
Why?
|
Prenylation | 1 | 2009 | 37 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1887 | 0.020 |
Why?
|
X Chromosome | 1 | 1993 | 819 | 0.020 |
Why?
|
Fluorescence | 1 | 1992 | 756 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15948 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3568 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 81762 | 0.020 |
Why?
|
Diffusion of Innovation | 1 | 2014 | 724 | 0.020 |
Why?
|
Salicylates | 1 | 2009 | 128 | 0.020 |
Why?
|
Telomerase | 1 | 2014 | 751 | 0.020 |
Why?
|
Cell Membrane | 1 | 1998 | 3655 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13671 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2014 | 872 | 0.020 |
Why?
|
Retina | 1 | 1999 | 2662 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 1996 | 1997 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 1009 | 0.020 |
Why?
|
United States | 4 | 2018 | 73039 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 615 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1906 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 1493 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1338 | 0.020 |
Why?
|
China | 1 | 2014 | 2395 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2009 | 669 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2009 | 406 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2536 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2011 | 1754 | 0.020 |
Why?
|
COS Cells | 1 | 2009 | 1135 | 0.020 |
Why?
|
Food Deprivation | 1 | 2007 | 114 | 0.020 |
Why?
|
Genome | 1 | 2015 | 1754 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2009 | 662 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3048 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2575 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1140 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2002 | 11244 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1542 | 0.020 |
Why?
|
Mutagens | 1 | 2007 | 181 | 0.020 |
Why?
|
Models, Genetic | 1 | 1997 | 3447 | 0.020 |
Why?
|
Computer-Assisted Instruction | 1 | 2010 | 366 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7454 | 0.020 |
Why?
|
Myocardium | 1 | 1999 | 4788 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2048 | 0.020 |
Why?
|
Blotting, Southern | 2 | 1998 | 775 | 0.020 |
Why?
|
Hamartoma | 1 | 2007 | 236 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6229 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1994 | 2433 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10632 | 0.010 |
Why?
|
Recurrence | 1 | 2017 | 8509 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1998 | 3533 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13290 | 0.010 |
Why?
|
Hemodynamics | 1 | 2014 | 4194 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1999 | 4978 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3252 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1133 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2007 | 717 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2007 | 778 | 0.010 |
Why?
|
Aspirin | 1 | 2014 | 3135 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2013 | 2907 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12840 | 0.010 |
Why?
|
Neurons | 1 | 2001 | 9514 | 0.010 |
Why?
|
Software | 1 | 2015 | 4478 | 0.010 |
Why?
|
Mental Disorders | 1 | 2001 | 6874 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3740 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 748 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2002 | 15832 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4428 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12795 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 671 | 0.010 |
Why?
|
Facial Neoplasms | 1 | 2000 | 126 | 0.010 |
Why?
|
Lymphokines | 1 | 2002 | 924 | 0.010 |
Why?
|
Graft Survival | 1 | 2009 | 3887 | 0.010 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 1998 | 46 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21538 | 0.010 |
Why?
|
ral Guanine Nucleotide Exchange Factor | 1 | 1997 | 4 | 0.010 |
Why?
|
rap GTP-Binding Proteins | 1 | 1997 | 24 | 0.010 |
Why?
|
DNA Damage | 1 | 2007 | 2469 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 5403 | 0.010 |
Why?
|
Penetrance | 1 | 1998 | 385 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2000 | 1903 | 0.010 |
Why?
|
Ploidies | 1 | 1996 | 287 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41754 | 0.010 |
Why?
|
Radiation Chimera | 1 | 1995 | 216 | 0.010 |
Why?
|
Pregnancy | 2 | 2013 | 30256 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 1995 | 114 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 1994 | 21 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 59629 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1997 | 958 | 0.010 |
Why?
|
Genes | 1 | 1997 | 1824 | 0.010 |
Why?
|
Family Health | 1 | 1998 | 1255 | 0.010 |
Why?
|
Chromosome Banding | 1 | 1993 | 261 | 0.010 |
Why?
|
Introns | 1 | 1994 | 966 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4168 | 0.010 |
Why?
|
Gene Library | 1 | 1994 | 1064 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2631 | 0.010 |
Why?
|
Cricetinae | 1 | 1995 | 2423 | 0.010 |
Why?
|
DNA Probes | 1 | 1992 | 542 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3514 | 0.010 |
Why?
|
Polydeoxyribonucleotides | 1 | 1992 | 136 | 0.010 |
Why?
|
DNA Primers | 1 | 1994 | 2828 | 0.010 |
Why?
|
Child, Preschool | 2 | 2001 | 42669 | 0.000 |
Why?
|
Placenta | 1 | 1994 | 1725 | 0.000 |
Why?
|